| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 4 | 5 | 2007 | 2020 | |||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.400 | None | 1.000 | 1 | 2 | 2010 | 2016 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 14 | 58 | 1998 | 2019 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.500 | None | 1.000 | 0 | 5 | 2008 | 2019 | ||||||||
|
endoplasmic reticulum aminopeptidase 2 | 0.615 | 0.577 | 1.0E-28 |
|
disease | 0.420 | None | 1.000 | 1 | 4 | 2010 | 2017 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.400 | None | 0.750 | 1 | 0 | 1997 | 2019 | ||||||||
|
macrophage stimulating 1 | 0.465 | 0.885 | 4.8E-19 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2008 | 2018 | ||||||||
|
solute carrier family 22 member 5 | 0.608 | 0.731 | 5.3E-16 |
|
disease | 0.400 | None | 0.912 | 0 | 0 | 2003 | 2016 | ||||||||
|
fucosyltransferase 2 | 0.552 | 0.731 | 5.3E-14 |
|
disease | 0.500 | None | 1.000 | 1 | 4 | 2010 | 2020 | ||||||||
|
vitronectin | 0.509 | 0.769 | 1.5E-10 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2016 | ||||||||
|
family with sequence similarity 92 member B | 0.839 | 0.038 | 4.8E-10 |
|
disease | 0.330 | None | 0.500 | 1 | 0 | 2007 | 2012 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 1999 | 2006 | ||||||||
|
G protein-coupled bile acid receptor 1 | 0.548 | 0.731 | 1.4E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.500 | None | 0.940 | 1 | 1 | 2004 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
solute carrier family 22 member 4 | 0.603 | 0.769 | 1.8E-08 |
|
disease | 0.500 | None | 0.896 | 0 | 2 | 2003 | 2017 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.620 | None | 0.800 | 1 | 2 | 2010 | 2016 | ||||||||
|
neutrophil cytosolic factor 4 | 0.644 | 0.615 | 9.0E-08 |
|
disease | 0.450 | None | 0.714 | 1 | 1 | 2007 | 2017 | ||||||||
|
toll like receptor 9 | 0.411 | 0.885 | 9.8E-06 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2004 | 2018 | ||||||||
|
interleukin 12B | 0.480 | 0.885 | 1.1E-04 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 2 | 23 | 2006 | 2020 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.880 | 1 | 5 | 1994 | 2019 |